Loading...
Organigram Global Inc.
OGI•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.53
$0.02(1.32%)
Organigram Global Inc. (OGI) Financial Performance & Income Statement Overview
Review Organigram Global Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
7.13%
↑ 7.13%
Operating Income Growth
85.30%
↑ 85.30%
Net Income Growth
80.20%
↑ 80.20%
Operating Cash Flow Growth
110.82%
↑ 110.82%
Operating Margin
-12.19%
↓ 12.19%
Gross Margin
32.69%
↑ 32.69%
Net Profit Margin
8.70%
↑ 8.70%
ROE
5.13%
↑ 5.13%
ROIC
-5.12%
↓ 5.12%
Organigram Global Inc. (OGI) Income Statement & Financial Overview
Review Organigram Global Inc.'s (OGI) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $42.73M | $44.70M | $41.06M | $37.63M |
| Cost of Revenue | $28.92M | $27.48M | $27.05M | $38.54M |
| Gross Profit | $13.81M | $17.22M | $14.008M | -$908000.00 |
| Gross Profit Ratio | $0.32 | $0.39 | $0.34 | -$0.02 |
| R&D Expenses | $2.37M | $1.67M | $2.46M | $2.61M |
| SG&A Expenses | $17.19M | $14.30M | $15.63M | $20.86M |
| Operating Expenses | $25.12M | $16.93M | $19.06M | $23.47M |
| Total Costs & Expenses | $54.03M | $44.41M | $46.11M | $62.005M |
| Interest Income | $0.00 | $0.00 | $0.00 | $715000.00 |
| Interest Expense | $0.00 | $0.00 | $52000.00 | $65000.00 |
| Depreciation & Amortization | $3.39M | $3.07M | $3.04M | $3.13M |
| EBITDA | -$3.41M | $7.27M | $6.03M | -$23.80M |
| EBITDA Ratio | -$0.08 | $0.16 | $0.15 | -$0.56 |
| Operating Income | -$11.30M | $283000.00 | -$5.05M | -$24.38M |
| Operating Income Ratio | -$0.26 | $0.006 | -$0.12 | -$0.65 |
| Other Income/Expenses (Net) | -$11.65M | -$5.69M | $7.99M | -$2.73M |
| Income Before Tax | -$22.96M | -$5.40M | $2.94M | -$26.99M |
| Income Before Tax Ratio | -$0.54 | -$0.12 | $0.07 | -$0.72 |
| Income Tax Expense | $0.00 | $30000.00 | $0.00 | -$30000.00 |
| Net Income | -$22.96M | -$5.43M | $2.82M | -$27.07M |
| Net Income Ratio | -$0.54 | -$0.12 | $0.07 | -$0.72 |
| EPS | -$0.20 | -$0.05 | $0.03 | -$0.30 |
| Diluted EPS | -$0.20 | -$0.05 | $0.03 | -$0.30 |
| Weighted Avg Shares Outstanding | $113.65M | $104.37M | $104.37M | $91.16M |
| Weighted Avg Shares Outstanding (Diluted) | $113.65M | $108.38M | $108.38M | $91.16M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan